Yorktown Heights, NY, United States of America

Gang Chen

This inventor holds 78 USPTO granted patents and 30 published patent applications and 17 EPO patents, primarily in Antibody Engineering (CPC class C07K). Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gang Chen. Retrieved from https://idiyas.com/inventor/gang-chen-18sps9t1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 78 (Patent Applications = 30)

% Patents Active = 89.7

EPO Patents = 17 (Patent Applications = 26)

Average Co-Inventor Count = 4.2

ph-index = 14

Forward Citations = 707(Granted Patents)

Forward Citations (Not Self Cited) = 564(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

77 out of 1,482

Regeneron Pharmaceuticals, Inc.

patents

1 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Antibody

High Affinity

CHO Integration

SARS-CoV-2

Eukaryotic Cells

Production Enhancers

Fucosylation-Deficient

Bispecific Antibodies

Transmembrane Proteins

Cell Surface Capture

Expression-Enhancing Loci

Fusion Polypeptides

78 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698514 - MAMMALIAN CELLS COMPRISING INTEGRATED CAS9 GENES TO PRODUCE STABLE INTEGRATION SITES, AND MAMMALIAN CELLS COMPRISING STABLE INTEGRATION SITES AND OTHER SITES (2026-08-04),

2. 12577326 - Recombinant Cell Surface Capture Proteins (2026-03-17),

3. 12577304 - ANTI-CD3 ANTIBODIES WITH LOW BINDING AFFINITY (2026-03-17),

4. 12565667 - CHO INTEGRATION SITES AND USES THEREOF (2026-03-03),

5. 12545735 - ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF (2026-02-10),

6. 12528883 - COMPOSITIONS AND METHODS FOR MAKING ANTIBODIES BASED ON USE OF EXPRESSION-ENHANCING LOCI (2026-01-20),

7. 12503520 - COMPOSITIONS AND METHODS FOR MAKING ANTIBODIES BASED ON USE OF AN EXPRESSION-ENHANCING LOCUS (2025-12-23),

8. 12480947 - Method for generating high affinity antibodies (2025-11-25),

9. 12466870 - NY-ESO-1 T CELL RECEPTORS AND METHODS OF USE THEREOF (2025-11-11),

10. 12371487 - Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same (2025-07-29),

11. 12251440 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2025-03-18),

12. 12234472 - Eukaryotic cells comprising adenovirus-associated virus polynucleotides (2025-02-25),

13. 12054751 - Fucosylation-deficient cells (2024-08-06),

14. 11808766 - Method for generating high affinity antibodies (2023-11-07),

15. 11788102 - CHO integration sites and uses thereof (2023-10-17),

Title: The Innovative Journey of Gang Chen

Introduction: Gang Chen, a pioneering inventor based in Yorktown Heights, NY, has made significant contributions to the field of technology and innovation.

Latest Patents: Gang Chen holds several patents in the areas of renewable energy, advanced materials, and nanotechnology, showcasing his commitment to pushing the boundaries of scientific discovery.

Career Highlights: With a background in engineering and a passion for sustainable solutions, Gang Chen has led groundbreaking research projects that have revolutionized industries worldwide. His work has been instrumental in shaping the future of clean energy and environmental conservation.

Collaborations: Throughout his career, Gang Chen has collaborated with leading research institutions, universities, and companies to further his innovative ideas. His partnerships have resulted in groundbreaking inventions that have garnered international recognition.

Conclusion: Gang Chen's relentless pursuit of innovation and his dedication to creating a more sustainable world have solidified his position as a visionary inventor. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.